ofa semaglutide lawsuit TSR STAFF: Lawrencia G! @lawrencia.cg #Ozempic, a drug used for diabetes and widely popular for weight loss, is now at the center of a huge pharmaceutical lawsuit. More than 1,800 lawsuits Ozempic, Wegovy, and other weight-loss

Individuals with seizure disorders or psychiatric conditions should exercise caution, as high ammonia levels may exacerbate these conditions

I took her seriously

These mechanisms do not prove benefit, but they explain why the scientific community is increasingly interested in GLP-1 drugs within the context of chronic inflammatory gynecologic disease

ATC 2nd level Pharmacological or Therapeutic subgroup ATC 3rd& 4th levels Chemical, Pharmacological or Therapeutic subgroup ATC 5th level Chemical substance The 2nd, 3rd and 4th levels are often used to identify pharmacological subgroups when that is considered more appropriate than therapeutic or chemical subgroups

Race, BMI, radiation, chemotherapy history, pre-existing diagnosis of diabetes, lymphedema development after ALND, and the use of GLP-1RAs were analyzed

They urge a precaution of use in patients with psychiatric disorders or at psychological risk, and suggest a warning be added to all semaglutide packaging (the FDA label of semaglutide for Wegovy currently warns to monitor for depression or suicidal thoughts)